Global Epinephrine Injection Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Epinephrine Injection market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Epinephrine Injection market."
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.

The global Epinephrine Injection market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Epinephrine Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Epinephrine Injection market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Mylan Inc
    Impax
    ALK Abello
    Lincoln Medical Ltd
    Pfizer
    Amphastar
    Emerade
    Grand Pharma
    Harvest Pharmaceuticals
    Merit Pharmaceutical
    Tianjin Jinyao Group

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Epinephrine Auto-injector
    Epinephrine Prefilled Syringe
    Combination Epinephrine Products

Segment by Application
    Anaphylaxis
    Cardiac Arrest
    Others